The licensed anthrax vaccine and many of the new anthrax vaccines being developed are based on protective antigen (PA), a nontoxic component of anthrax toxin. For this reason, an understanding of the immune response to PA vaccination is important. In this study, we examined the antibody response elicited by PA-based vaccines and identified the domains of PA that contribute to that response in humans as well as nonhuman primates (NHPs) and rabbits, animal species that will be used to generate efficacy data to support approval of new anthrax vaccines. To this end, we developed a competitive enzyme-linked immunosorbent assay (ELISA), using purified recombinant forms of intact PA and its individual domains. We found that PA-based vaccines elicited IgG antibodies to each of the four PA domains in all three species. We also developed a competitive toxin neutralization assay, which showed that rabbits, NHPs, and humans all have functional antibody populations that bind to domains 1, 3, and 4. While the domain specificities of the antibody responses elicited by PA-based vaccines were similar in humans, NHPs, and rabbits, competitive assays suggested that humans may have a more significant secondary population of IgG antibodies that bind to partially unfolded or incorrectly folded PA. These findings provide information that will be useful when linking animal protection data to humans via an antibody bridge to establish efficacy of new anthrax vaccines.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2944443 | PMC |
| http://dx.doi.org/10.1128/CVI.00145-10 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Are we ready for the next anthrax outbreak? Lessons from a simulation exercise in a rural-based district in Uganda.
Epidemiol Infect
December 2024
Department of Wildlife, Animal Resources Management, College of Veterinary Medicine, Animal Resources and Biosecurity, Makerere University, Kampala, Uganda.
Anthrax is a bacterial zoonotic disease caused by We qualitatively examined facilitators and barriers to responding to a potential anthrax outbreak using the capability, opportunity, motivation behaviour model (COM-B model) in the high-risk rural district of Namisindwa, in Eastern Uganda. We chose the COM-B model because it provides a systematic approach for selecting evidence-based techniques and approaches for promoting the behavioural prompt response to anthrax outbreaks. Unpacking these facilitators and barriers enables the leaders and community members to understand existing resources and gaps so that they can leverage them for future anthrax outbreaks.
View Article and Find Full Text PDFIdentification of molecular and cellular infection response biomarkers associated with anthrax infection through comparative analysis of gene expression data.
Comput Biol Med
January 2025
ICAR-National Institute of Veterinary Epidemiology and Disease Informatics, Bengaluru, Karnataka, 560064, India. Electronic address:
Bacillus anthracis, a gram-positive bacillus capable of forming spores, causes anthrax in mammals, including humans, and is recognized as a potential biological weapon agent. The diagnosis of anthrax is challenging due to variable symptoms resulting from exposure and infection severity. Despite the availability of a licensed vaccines, their limited long-term efficacy underscores the inadequacy of current human anthrax vaccines, highlighting the urgent need for next-generation alternatives.
View Article and Find Full Text PDFLouis Pasteur: A Legacy Unmasked.
Cureus
August 2024
Community Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education & Research, Wardha, IND.
Article Synopsis
- Louis Pasteur is a prominent French scientist known for his discoveries in molecular chirality and fermentation, which greatly helped the brewing and winemaking industries.
- He developed pasteurization and made significant contributions to germ theory, aiding in antiseptic surgery and the creation of vaccines for diseases like anthrax and rabies.
- Despite facing criticism for his vaccination techniques and initial debates over disease causes, historians now recognize Pasteur's substantial impact on science and medicine, clarifying many misconceptions about his work.
Comprehensive Spatial-Temporal and Risk Factor Insights for Optimizing Livestock Anthrax Vaccination Strategies in Karnataka, India.
Vaccines (Basel)
September 2024
ICAR-National Institute of Veterinary Epidemiology & Disease Informatics, Bengaluru 560064, Karnataka, India.
Article Synopsis
- Anthrax is a zoonotic disease impacting livestock and humans, and the study aimed to identify environmental risk factors to create a better predictive risk map for vaccination.
- Researchers analyzed anthrax data from 2000-2023 in Karnataka, using machine learning to examine factors like temperature and soil quality to uncover spatial patterns and high-risk areas.
- The findings identified 11 high-risk districts with a basic reproduction number (Ro) greater than 1.50, suggesting targeted vaccination strategies, with herd immunity thresholds varying from 11.24% to 55.47%.
Re-inventing traditional aluminum-based adjuvants: Insight into a century of advancements.
Int Rev Immunol
September 2024
Amity Institute of Microbial Technology, Amity University Rajasthan, Jaipur, India.
Aluminum salt-based adjuvants like alum, alhydrogel and Adju-Phos are by far the most favored clinically approved vaccine adjuvants. They have demonstrated excellent safety profile and currently used in vaccines against diphtheria, tetanus, pertussis, hepatitis B, anthrax etc. These vaccinations cause minimal side effects like local inflammation at the injection site.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!